FI904756A0 - Stabiliserade leukocyt-interferoner. - Google Patents

Stabiliserade leukocyt-interferoner.

Info

Publication number
FI904756A0
FI904756A0 FI904756A FI904756A FI904756A0 FI 904756 A0 FI904756 A0 FI 904756A0 FI 904756 A FI904756 A FI 904756A FI 904756 A FI904756 A FI 904756A FI 904756 A0 FI904756 A0 FI 904756A0
Authority
FI
Finland
Prior art keywords
interferoner
leukocyt
stabilizer
stabilizer leukocyt
Prior art date
Application number
FI904756A
Other languages
English (en)
Finnish (fi)
Inventor
Alberto Ferro
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI904756A0 publication Critical patent/FI904756A0/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI904756A 1989-09-28 1990-09-27 Stabiliserade leukocyt-interferoner. FI904756A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH351489 1989-09-28

Publications (1)

Publication Number Publication Date
FI904756A0 true FI904756A0 (fi) 1990-09-27

Family

ID=4257630

Family Applications (1)

Application Number Title Priority Date Filing Date
FI904756A FI904756A0 (fi) 1989-09-28 1990-09-27 Stabiliserade leukocyt-interferoner.

Country Status (26)

Country Link
EP (1) EP0420049B1 (is)
JP (1) JPH03130232A (is)
KR (1) KR910005886A (is)
CN (1) CN1050503A (is)
AR (1) AR244551A1 (is)
AT (1) ATE92334T1 (is)
AU (1) AU636653B2 (is)
CA (1) CA2024046A1 (is)
CZ (1) CZ277712B6 (is)
DD (1) DD298054A5 (is)
DE (1) DE59002183D1 (is)
FI (1) FI904756A0 (is)
HU (1) HU205555B (is)
IE (1) IE903479A1 (is)
IL (1) IL95769A0 (is)
IS (1) IS3631A7 (is)
MC (1) MC2149A1 (is)
MX (1) MX22522A (is)
MY (1) MY106615A (is)
NO (1) NO904218L (is)
NZ (1) NZ235153A (is)
PH (1) PH27531A (is)
PT (1) PT95454A (is)
RU (1) RU2008017C1 (is)
YU (1) YU184090A (is)
ZA (1) ZA907579B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6794194A (en) * 1993-05-18 1994-12-20 Bukh Meditec A/S A method for the preparation of interferons
ES2184084T3 (es) * 1996-05-09 2003-04-01 Feronpatent Ltd Estabilizacion de interferones en disolucion acuosa para la fabricacion de pastillas de administracion sublingual.
JP2001526662A (ja) * 1997-05-09 2001-12-18 フェロンパテント リミテッド 舌下投与式タブレットの製造のための水溶液におけるインターフェロンの安定化
US6180096B1 (en) 1998-03-26 2001-01-30 Schering Corporation Formulations for protection of peg-interferon alpha conjugates
IL138221A0 (en) * 1998-03-26 2001-10-31 Schering Corp Formulations for protection of peg-interferon alpha conjugates
CN1175901C (zh) * 1999-12-06 2004-11-17 天津华立达生物工程有限公司 一种稳定的干扰素水溶液
JP4971160B2 (ja) 2004-08-12 2012-07-11 シェーリング コーポレイション 安定するpeg化インターフェロン処方物
DE102004048379A1 (de) 2004-10-01 2006-04-13 "Stiftung Caesar" (Center Of Advanced European Studies And Research) Federelement aus gesputterter Formgedächtnis-Legierung
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
ATE31023T1 (de) * 1983-04-28 1987-12-15 Armour Pharma Pharmazeutische zubereitung mit gehalt an gereinigtem fibrinonectin.
EP0133767B1 (en) * 1983-08-04 1991-04-03 The Green Cross Corporation Gamma interferon composition
PT82249B (en) * 1985-03-25 1988-01-07 Schering Corp Process for preparing stable gamma-interferon formulations
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones

Also Published As

Publication number Publication date
CN1050503A (zh) 1991-04-10
DE59002183D1 (de) 1993-09-09
NO904218D0 (no) 1990-09-27
MC2149A1 (fr) 1992-03-10
AU636653B2 (en) 1993-05-06
CA2024046A1 (en) 1991-03-29
NO904218L (no) 1991-04-02
CS432890A3 (en) 1992-12-16
RU2008017C1 (ru) 1994-02-28
HU205555B (en) 1992-05-28
NZ235153A (en) 1993-03-26
KR910005886A (ko) 1991-04-27
DD298054A5 (de) 1992-02-06
EP0420049A1 (de) 1991-04-03
MX22522A (es) 1993-10-01
EP0420049B1 (de) 1993-08-04
AR244551A1 (es) 1993-11-30
HUT56284A (en) 1991-08-28
AU6309890A (en) 1991-04-11
IE903479A1 (en) 1991-04-10
PT95454A (pt) 1991-05-22
YU184090A (sh) 1992-09-07
CZ277712B6 (en) 1993-03-17
PH27531A (en) 1993-08-18
MY106615A (en) 1995-06-30
JPH03130232A (ja) 1991-06-04
HU906021D0 (en) 1991-03-28
IS3631A7 (is) 1991-03-29
ZA907579B (en) 1991-06-26
IL95769A0 (en) 1991-06-30
ATE92334T1 (de) 1993-08-15

Similar Documents

Publication Publication Date Title
FI914133A0 (fi) Svaengbar kopplingsanordning.
FI890828A0 (fi) Konditionsdon.
DE69002184D1 (de) Stabilisator.
DE59003341D1 (de) Radaufhängung.
DE69012802D1 (de) Stabilisatorstange.
FI910566A0 (fi) Stabiliserad polymerlatexkomposition.
NO900159D0 (no) Oppheng.
FI904756A0 (fi) Stabiliserade leukocyt-interferoner.
DE69011984D1 (de) Aufhängungselement.
DE69010340D1 (de) Aufhängungsanordnung.
DE69004689D1 (de) N-fluoropyridinium-pyridin-heptafluorodiborat.
FI891532A0 (fi) Skaerningsanordning.
FI892042A0 (fi) Tryckledning.
FI892647A (fi) Kondensorkonstruktion.
FI895850A0 (fi) Vaoningssaeng.
FI890855A0 (fi) Skidstavstruga.
FI871027A0 (fi) Stabiliserat slirskydd foer fordonsdaeck.
FI904567A0 (fi) Staol foer formgjutningar.
FI890322A0 (fi) Uppstaellning foer regleringsvaexel.
FI891187A0 (fi) Bastuugn.
DE59001865D1 (de) Drehkreuz.
ATE103894T1 (de) Indolderivate.
ATE102114T1 (de) Brieflocher.
FI892811A0 (fi) Skakningsdaempare foer skakschaktsblad.
FI892551A (fi) Patientradar.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: F. HOFFMANN - LA ROCHE AG